The EU Commission sends statement of objections for alleged pay-for-delay agreement (Teva)

On 17 July 2017, the European Commission issued a Statement of Objections against pharmaceutical companies Teva and Cephalon (which is now a subsidiary of Teva) alleging that Teva breached Article 101 TFEU by concluding an agreement with Cephalon not to market a

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Peter L'Ecluse, The EU Commission sends statement of objections for alleged pay-for-delay agreement (Teva), 17 July 2017, e-Competitions Bulletin July 2017, Art. N° 84750

Visites 162

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues